Investigation of Antituberculosis from Medicinal Plant of Community Ethnis in South Sulawesi.

Investigation of Antituberculosis from Medicinal Plant of Community Ethnis in South Sulawesi.

Rante, Herlina;Alam, Gemini;Sartini, ;Permana, Andi Dian;Usmar, ;Burhamzah, Rahmita;Ali, Alimuddin;Budiarti, Mery;
infectious disorders drug targets 2019
137
rante2019investigationinfectious

Abstract

The aim of this research was to know the species of plant that is used as anti-hematemesis medicine that has the activity of antituberculosis and antituberculosis-MDR and then investigate the phytochemistry characteristics of the compound from every parts of the plant extract that show the activity of antituberculosis and antituberculosis-MDR which is indicated by the value of Minimum Inhibitory Concentration (MIC) of the exctracts.Tuberculosis is one of the transmitted disease that has been claimed as one of the serious health problem in the world that can cause death as reported in WHO in Global Tuberculosis Report 2014. It has been predicted that 9 million of people suffers tuberculosis disease and 1.5 - 2 million people has dead by this disease.Discovery of antituberculosis and antituberculosis MDR agent from medicinal plant of communtity ethnis in south sulawesimethodThe extraction method used in this research was maceration method. The antituberculosis activity test was investigated using MODS and LJ methods. The isolation of the active compound was carried out using Bioassay Guided Fractination and then the compound characteristics were identified using spectroscopy data.The results showed that extracts from Talas and Kariango plants were active against M. tuberculosis. The FTIR data showed that three isolates obtained from Talas plants contained aliphatic OH and C-O and CH groups. The MIC values of kariango and Talas extracts using the MODS method were 45 mg / ml and 40 mg / ml, respectively.Talas (Collocasia esculenta) tuber and Kariango rhizome ethanolic extract have a potency for antituberculosis and anti-MDR tuberculosis drug.

Citation

ID: 107164
Ref Key: rante2019investigationinfectious
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
107164
Unique Identifier:
10.2174/1871526520666191216121302
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet